cardiac arrest (OHCA) patients, but data on the long-term survival are scarce. We performed a study to assess long-term survival in OHCA patients managed with CA on admission and PCI if indicated and to compare survival between patients with and without acute myocardial infarction (AMI). Methods: Retrospective single-centre study including patients !18 y.o. resuscitated from an OHCA without an obvious non-cardiac cause. AMI was diagnosed angiographically as lesions suggestive of ruptured plaques with fresh thrombus and critical stenosis easily crossed by an angioplasty wire. Survival was recorded at discharge and 5-years survival probability was estimated by Kaplan-Meier survival curves. Data are expressed as numbers (percentages) and median (interquartile range-IQR). Results: 300 comatose patients aged 56 (48-67) were included from 2002 to 2011. 130 patients (43%) had ventricular fibrillation, 116 (39%) asystole, 54 (18%) had other/unknown initial rhythm. All patients had CA on admission and 93 (31%) had an AMI. PCI was attempted in 85 (91%) of AMI patients, successful in 79. Therapeutic hypothermia was performed in 256 (84%) patients. Survival at discharge was 32.3% (97/300). After discharge, 5-year probability of survival was 81.7AE5.4%. Probability of survival from admission to 5 years was 26.2%AE2.8%. AMI patients had better survival at discharge, 40.8% (38/93) versus 28.5% (59/207) in non-AMI, p¼0.047. Probability of survival from discharge to 5 years in AMI patients was 92.2%AE5.4% versus 73.4AE8.6% in non-AMI, hazard ratio (HR)¼2.7, confidence interval (CI)¼(0.8-8.9), p¼0.1. Survival probability from admission to 5 years was better for AMI patients, 37.4%AE5.2% versus, 20.7%AE3.0% in non-AMI, HR¼1.5, CI¼(1.12-2.0), p¼0.0067. Conclusions: We observed a very favourable post-discharge prognosis in OHCA patients undergoing on-admission CA with PCI if indicated. Patients suffering OHCA due to AMI had better survival to discharge and at 5 years follow-up than patients suffering OHCA due to other causes. Background: It has been advocated that LTBL treatment in the context of p-PCI may lead to unsuccessful angiographic reperfusion and unfavorable clinical outcome, suggesting that thrombus aspiration should be considered in this subset. However, the hazard of LTBL treatment on myocardial reperfusion and damage has not been evaluated. This study aims to investigate the impact of large thrombus burden lesion (LTBL) on myocardial damage, using CE-CMR in the setting of primary-PCI (p-PCI). Methods: In 327 patients, who underwent p-PCI without mechanical device use, within 12-hours from symptom onset, we prospectively assessed the impact of LTBL on infarct size and microvascular damage, using CE-CMR. LTBL was defined by the presence of TIMI-thrombus score ! 3 in patent IRAs; or by "cut off" occlusion pattern and/or large reference vessel diameter (! 3.5 mm) in occluded IRAs Results: 197 (60.2%) patients showed LTBL, and 130 (39.8%) did not. Distal embolization (DE) occurred in 18.8% LTBL vs 6.9% no-LTBL patients (p¼0.003). At CE-MR, patients with LTBL had larger infarct size index (27.5+11.1 vs 22.1+17.5, p¼0.009), and more often transmural necrosis (70.5% vs55.4%, p¼0.008) compared to patients without LTBL. After excluding patients with DE, LTBL patients still had larger necrosis. At multivariate analysis, occluded (IRA) at baseline, anterior infarction, and occurrence of distal embolization predicted transmural necrosis. Conclusions: Treatment LTBL in the setting of P-PCI is related to larger myocardial damage as detected by CE-CMR, regardless of angiographic detectable embolization. These findings suggest that in patients with LTBL thrombus aspiration before stenting should be considered.
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TCT-257
In Background: Inappropriate activation (IA) of the cardiac catheterization laboratory for code STEMI is associated with significant time and health care costs. The clinical outcome of patients with IA has not been characterized. The objective of this study was to determine the reasons for IA and to evaluate the short-term outcome of these patients. Methods: From January, 2009 through September, 2011, 396 patients initially activated for code STEMI were evaluated. Patients that underwent emergent coronary angiography with or without PCI were considered as appropriate activation (AA Group, n ¼228); patients that were subsequently cancelled and did not undergo emergent coronary angiography were considered as inappropriate activation (IA Group, n¼168). Baseline demographics, findings of initial ECG, reasons for cancellation and in-hospital outcome were collected. Results: Mean age was 57AE8 years and 73% were male. The most common initial ECG findings for the IA group were ST segment elevation <1 mm (55%), arrhythmias (23%), bundle branch block (22%) and left ventricular hypertrophy (18%). The most common reasons for code STEMI cancellation were absence of ST segment elevation >1 mm (83%), coexisting severe medical condition (10%) and a normal bedside echocardiogram in the setting of an equivocal ECG (15%). In-hospital mortality was significantly worse for the IA Group compared to the AA Group, 17.3% vs 7%, p¼0.002, respectively. Conclusions: Abnormalities of rhythm and conduction and left ventricular hypertrophy account for the majority of ECG findings for IA. The lack of ST segment elevation >1 mm was the most common reason for code STEMI cancellation. Shortterm mortality for patients with IA is significantly higher than in patients with STEMI. These findings suggest that additional treatment strategies for code STEMI cancellation should be explored.
TCT-258 Elaboration of a New Risk Score for Predicting Distal Embolization during Primary Angioplasty in ST-Elevation Myocardial Infarction
Massimo Napodano Background: Distal embolization (DE) is a serious complication of primary-PCI for ST-elevation myocardial infarction, affecting mortality and morbidity rate. This study aims to develop and validate a new angiographic risk score to predict the risk of DE in patients undergoing p-PCI. Methods: Study sample included data from 1200 pts undergoing p-PCI. Logistic regression was used to examine the relationship between risk factors and occurrence of DE. The cohort was randomly divided into a risk score development cohort (n¼814), and a validation cohort (n ¼386). Each covariate in the model was assigned an integer score based on the regression coefficients. Results: The rate of DE was 14.4%, with in-hospital mortality of 9.8%. At multivariate analysis, four variables resulted independent predictors of DE: the "cut-off " occlusion pattern of infarct-related artery, TIMI thrombus score 2-4, RVD ! 3.5 mm, lesion length > 20 mm. Each variable was assigned a 0 to +2 points according to the strength of the statistical association. Risk scores 0 to 1 were considered low risk, 2 to 4 intermediate risk, and 5 to 7 high risks for DE. DE was different among risk score groups in both derivation cohort (p for trend < 0.0001; C-statistic 0.68) and in validation cohort (p for trend <0.0001; C-statistic 0.64).
Conclusions:
The individual risk of distal embolization can be predicted using simple 4-variable model. The application of this new risk score can be useful in strategies making during p-PCI in STEMI, particularly in selecting patients who may benefit from pharmacological and adjunctive mechanical thrombus removal.
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